Foreign investors withdrew ₹1.67 trillion from Indian equities in 2025, favouring cyclical sectors like telecom and oil.
The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report ...
Calidris Investment Partners ('Calidris”), an insurance-focused investment manager backed by RedBird Capital Partners, today ...
My investment approach has shifted from yield-centric to growth-focused. Read how the 5% Rule can function as a strategic ...
Tata Motors CCO Vivek Srivatsa explains Punch facelift strategy, turbo petrol debut, safety focus and how first-time car ...
Generative AI as a Strategic Enabler for Global Start-Ups Entering Southeast Asian Markets: Capabilities, Illustrative Cases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results